FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type Ifda.govMar 26, 04:00 AM
FDA Approves Fourth Product Under National Priority Voucher Program, Higher Dose Semaglutidefda.govMar 19, 02:30 PM